Biotherapy International

Partner Clinic in Germany

Biotherapy International Biotherapy International – Partner Clinic in Germany

The Biotherapy International partner clinic in Germany is located in the city of Rheinfelden, near the Swiss border. Here, patients gain access to innovative cancer immunotherapy and regenerative medicine programs developed under the direction of Professor Shimon Slavin, M.D. This collaboration provides patients from Europe and around the world access to personalized treatment under medical supervision following Biotherapy International protocols.

Biotherapy International Germany branch

Cancer Immunotherapy in Germany

At partner clinic in Germany, cancer immunotherapy programs are designed for patients who require individualized treatment approaches when standard therapies have reached their limits. In Germany, a number of innovative compassionate-use therapies are permitted, allowing patients to access advanced immunotherapy methods aimed at supporting their treatment course and quality of life. All protocols are carried out under the medical supervision of Biotherapy International’s Israeli team, ensuring consistent clinical standards and patient safety.

Cancer Immunotherapy Methods, We Utilize in Germany

  • Oncolytic viruses. Human-safe oncolytic viruses that bind to tumor receptors, trigger the destruction of malignant cells, and make them recognizable to the immune system.
  • Cancer vaccines. Personalized cancer vaccines that stimulate the patient’s own immune system to target and destroy cancer cells.
  • ATACK. Allogeneic Targeted Activated Cancer Killer cells – intentionally mismatched cells designed to directly destroy tumors resistant to other treatments.
  • Photodynamic therapy (PDT). A light-activated treatment that uses photosensitizing agents to selectively damage cancer cells while sparing surrounding healthy tissue.

Stem Cell Therapy in Germany

The clinic in Germany also provides access to regenerative therapy programs based on autologous and allogeneic mesenchymal stem cells (MSCs). These methods aim to restore damaged tissues, reduce chronic inflammation, and help regain lost functions in patients with neurodegenerative, autoimmune, and other complex diseases.

All procedures are performed by the local medical team under the supervision of Biotherapy International’s Israeli center, in full compliance with German and international medical standards.

Q&A

What types of cancer immunotherapy are available at the German clinic?
Depending on the clinical case, the individualized protocol may include oncolytic virus therapy, the ATACK method, photodynamic therapy (PDT), personalized cancer vaccines, and other methods.
Are international patients accepted in Germany?
Yes. Patients from any country can receive treatment at the German partner clinic after completing an online consultation and receiving a personalized protocol.
How is the treatment schedule organized?
After the consultation, the patient receives an individualized protocol describing the recommended procedures, timeframes, and expected treatment duration. Our coordinators arrange all necessary steps with the German clinic and provide logistical support to the patient.
Do patients need to stay in Germany for the entire treatment period?
Not always. For cancer immunotherapy, most patients stay in Germany for 8–15 days, depending on the protocol. For mesenchymal stem cell (MSC) therapy, the visit is significantly shorter and typically takes about 3 days. The exact schedule is determined by the individual treatment plan.
Does the clinic in Germany accept patients with brain cancer?
Yes, patients with glioblastoma and other types of brain cancer can receive treatment at our partner clinic in Germany. The individualized protocol may include oncolytic viruses, the ATACK method, photodynamic therapy (PDT), and other immunotherapy approaches. If the patient has an Ommaya reservoir in place, some medications can be administered through it.
Is Professor Slavin physically present during treatment in Germany?
No. The procedures are performed by the medical team at the partner clinic. Professor Slavin remains responsible for the treatment plan, provides remote supervision, and adjusts the protocol when necessary.
Contact Us